Managing Mutations in Non-Small Cell Lung Cancer

Three experts discuss advanced non-small cell lung cancer and what it means to have a treat a KRAS G12C mutation.

June 22nd 2022

Joshua Sabari, MD, provides a breakdown of advanced non-small cell lung cancer (NSCLC) and its actionable mutations.

June 22nd 2022

Three medical experts highlight unmet needs they routinely run into while treating patients with NSCLC.

June 28th 2022

Alexander Spira, MD, PhD, FACP provides an overview of molecular testing in NSCLC.

June 28th 2022

Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers.